A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing

  • PDF / 854,529 Bytes
  • 7 Pages / 595.276 x 790.866 pts Page_size
  • 71 Downloads / 197 Views

DOWNLOAD

REPORT


(2020) 15:64

RESEARCH ARTICLE

Open Access

A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing Andrew Goldstein1*, Yang Lei2, Lena Goldstein3, Amelia Goldstein4, Qiao Xu Bai5, Juan Felix6, Roberta Lipson5, Maria Demarco7, Mark Schiffman7 , Didem Egemen7, Kanan T. Desai7, Sarah Bedell8, Janet Gersten8, Gail Goldstein9, Karen O’Keefe10, Casey O’Keefe11, Tierney O’Keefe12, Cathy Sebag13, Lior Lobel13, Anna Zhao5 and Yan Ling Lu5

Abstract Objective: Rapid, high-volume screening programs are needed as part of cervical cancer prevention in China. Methods: In a 5-day screening project in Inner Mongolia, 3345 women volunteered following a community awareness campaign, and self-swabbed to permit rapid HPV testing. Two AmpFire™ HPV detection systems (Atila Biosystems) were sufficient to provide pooled 15-HPV type data within an hour. HPV+ patients had same-day digital colposcopy (DC) performed by 1 of 6 physicians, using the EVA™ system (MobileODT). Digital images were obtained and, after biopsy of suspected lesions for later confirmatory diagnosis, women were treated immediately based on colposcopic impression. Suspected low- grade lesions were offered treatment with thermal ablation (Wisap), and suspected high-grade lesions were treated with LLETZ. Results: Of 3345 women screened, 624 (18.7%) were HPV+. Of these, 88.5% HPV+ women underwent same-day colposcopy and 78 were treated. Later consensus histology results obtained on 197 women indicated 20 CIN2+, of whom 15 were detected and treated/referred at screening (10 by thermal ablation, 4 by LLETZ, 1 by referral). Conclusions: Global control of cervical cancer will require both vaccination and screening of a huge number of women. This study illustrates a cervical screening strategy that can be used to screen-and-treat large numbers of women. HPV self-sampling facilitates high-volume screening. Specimens can be tested rapidly, promoting minimal loss-to-follow-up. Specifically, the AmpFire™ system used in this study is highly portable, simple, rapid (92 specimens per 65 min per unit), and economical. Visual triage can be performed on HPV+ women with a portable digital colposcope that provides magnification, lighting, and a recorded image. Diagnosis and appropriate treatment remain the most subjective elements. The digital image is under study for deep-learning based automated evaluation that could assist the management decision, either by itself or combined with HPV typing.

* Correspondence: [email protected] 1 Centers for Vulvovaginal Disease, Washington, DC, USA Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or